Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Maneesh Bhargava, Shu-Yi Liao, Elliott D. Crouser, Lisa A. Maier, Sonia M. Leach. The landscape of transcriptomic and proteomic studies in sarcoidosis. ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021

Member's Comments

No comment yet.

Related content which might interest you: Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes Source: Eur Respir J 2014; 44: 985-993 Year: 2014 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 A comparative proteomic profiling of the human erythrocyte membrane in COPD patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: ERS Lung Science Conference 2016 Year: 2016 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Transcriptome profiling reveals the complexity of pirfenidone effects in IPF. Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Integration of transcriptomics and metabolomics with microbiomic data to identify host-microbiota interactions Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome Year: 2019 From genomics to proteomics Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Identification of disease genes by expression profiling Source: Eur Respir J 2001; 18: 882-889 Year: 2001 Metabolomic analyses reveal new stage-specific features of COVID-19 Source: Eur Respir J, 59 (2) 2100284; 10.1183/13993003.00284-2021 Year: 2022 Endotyping bronchiectasis through multi-omic profiling Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019